Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer

Journal of Otolaryngology - Head and Neck Surgery

Volumn 42, Issue MAR, 2013, Pages

  Lin, Rui Jun ^a   Lubpairee, Tarinee ^b   Liu, Kelly Y ^a   Anderson, Donald W ^a   Durham, Scott ^a   Poh, Catherine F ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cyclin D1; Disease free survival; Human papillomavirus (HPV); Oropharyngeal squamous cell carcinoma (OpSCC); P16; Prognosis

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CYCLIN D1; PROTEIN P16; VIRUS DNA; CCND1 PROTEIN, HUMAN; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENDER; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NONHUMAN; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SMOKING; TISSUE MICROARRAY; TUMOR BIOPSY; AGED; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; METABOLISM; METHODOLOGY; MORTALITY; OROPHARYNX TUMOR; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VIROLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME;

EID: 84897003740     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.1186/1916-0216-42-23     Document Type: Article

References (27)

1. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26:612-9.
2. Sturgis EM, Ang KK: The epidemic of HPV-associated oropharyngeal cancer is here: is It time to change Our treatment paradigms? J Natl Compr Canc Netw 2011, 9:665-73.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al: Human papillomavirus and rising oropharyngeal cancer incidence in the united states. J Clin Oncol 2011, 29:4294-301.
4. Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-75.
5. Herrero R, Castellsagué X, Pawlita M, et al: Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Inst 2003, 95:1772-83.
6. Adelstein DJ, Ridge JA, Gillison ML, et al: Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008. 31st edition. Washington, D. C: Head & Neck; 2009:1393-422.
7. Andl T, Kahn T, Pfuhl A, et al: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998, 58:5-12.
8. Li W, Thompson CH, Cossart YE, et al: The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004, 26:1-9.
9. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S: Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 1996, 78:390-5.
10. Edge SBBD, Compton CC, et al: AJCC Cancer Staging Manual. 7th edition. New York, NY: Springer; 2010.
11. Chen B, Van Den Brekel MWM, Buschers W, Balm A J M, Van Velthuysen M-LF: Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 2003, 25:922-30.
12. O'Regan EM, Toner ME, Finn SP, et al: p16INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 2008, 39:452-8.
13. Wang J, Wang X, Gong W, Mi B, Liu S, Jiang B: Increased expression of β-catenin, phosphorylated glycogen synthase kinase 3β, cyclin D1, and c-myc in laterally spreading colorectal tumors. J Histochem Cytochem 2009, 57:363-71.
14. Mineta H, Miura K, Takebayashi S, et al: Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 2000, 36:194-8.
15. Jares P, Fernández PL, Campo E, et al: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994, 54:4813-7.
16. Perisanidis C, Perisanidis B, Wrba F, et al: Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 2012, 41:40-6.
17. Smith B, SGLCD, et al: MOlecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2001, 127:780-5.
18. Michalides R, VNJKPP, et al: OVerexpression of cyclin d1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997, 123:497-502.
19. Rasamny JJ, Allak A, Krook KA, et al: Cyclin D1 and FADD as Biomarkers in Head and Neck Squamous Cell Carcinoma. Otolaryngology. Head Neck Surg 2012, 146:923-31.
20. Hong AM, Dobbins TA, Lee CS, et al: Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer. Int J Cancer 2011, 128:1532-45.
21. Yu Z, Weinberger PM, Haffty BG, et al: Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res 2005, 11:1160-6.
22. Capaccio P, Pruneri G, Carboni N, et al: Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 2000, 22:234-40
23. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993, 7:812-21
24. Li Y, Nichols MA, Shay JW, Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994, 54:6078-82
25. Rischin D, Young RJ, Fisher R, et al: Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 Phase III trial. J Clin Oncol 2010, 28:4142-8
26. Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100:261-9
27. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35